Related references
Note: Only part of the references are listed.TIPE2 suppressed cisplatin resistance by inducing autophagy via mTOR signalling pathway
Hua Guo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44
He Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma
Xuewei Zhu et al.
ONCOTARGETS AND THERAPY (2020)
Integrative Analysis of NSCLC Identifies LINC01234 as an Oncogenic lncRNA that Interacts with HNRNPA2B1 and Regulates miR-106b Biogenesis
Zhenyao Chen et al.
MOLECULAR THERAPY (2020)
LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
Tianwei Xu et al.
FRONTIERS IN ONCOLOGY (2020)
HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression
Xiu Lei et al.
CELLULAR SIGNALLING (2020)
Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
Zhenyao Chen et al.
CELL DEATH & DISEASE (2020)
The progression of HMGB1-induced autophagy in cancer biology
Tianwei Xu et al.
ONCOTARGETS AND THERAPY (2019)
HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
Bi-Fei Huang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Targeting autophagy in obesity: from pathophysiology to management
Yingmei Zhang et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration
Xu Zhang et al.
MOLECULAR CANCER (2018)
The dual role and therapeutic potential of high-mobility group box 1 in cancer
Si-Jia He et al.
ONCOTARGET (2017)
MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMG B1-Mediated Autophagy
Yuqing Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Autophagy in cardiac metabolic control: Novel mechanisms for cardiovascular disorders
Yufei Yang et al.
CELL BIOLOGY INTERNATIONAL (2016)
Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress
Zhongliang Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
New and emerging targeted treatments in advanced non-small-cell lung cancer
Fred R. Hirsch et al.
LANCET (2016)
HMGB1 as biomarker and drug target
Emilie Venereau et al.
PHARMACOLOGICAL RESEARCH (2016)
Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells
Karthik Subramanian Chandrasekaran et al.
TUMOR BIOLOGY (2016)
Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy
Vito Pistoia et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
Jinpao Hou et al.
FRONTIERS IN GENETICS (2016)
Oligometastatic non-small-cell lung cancer: current treatment strategies
Patrick J. Richard et al.
LUNG CANCER-TARGETS AND THERAPY (2016)
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells
Shohei Sugita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer Cells
Jia-Tao Liu et al.
CLINICAL LUNG CANCER (2015)
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
Matthew G. Oser et al.
LANCET ONCOLOGY (2015)
Gefitinib and Erlotinib in Metastatic Non-Small Cell Lung Cancer: A Meta-Analysis of Toxicity and Efficacy of Randomized Clinical Trials
Mauricio Burotto et al.
ONCOLOGIST (2015)
Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis
Ruiguang Zhang et al.
TUMOR BIOLOGY (2015)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
Autophagy-a key player in cellular and body metabolism
Kook Hwan Kim et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Drug resistance to molecular targeted therapy and its consequences for treatment decisions in non-small-cell lung cancer
Johanna N. Spaans et al.
FRONTIERS IN ONCOLOGY (2014)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib
Yiyu Zou et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Role of autophagy in diabetes and endoplasmic reticulum stress of pancreatic β-cells
Wenying Quan et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs
Jin-Haeng Chung et al.
LUNG CANCER (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
High-mobility group box 1 and cancer
Daolin Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Inhibition of Autophagy by 3-MA Enhances the Effect of 5-FU-Induced Apoptosis in Colon Cancer Cells
Jie Li et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors
Marissa N. Balak et al.
CLINICAL CANCER RESEARCH (2006)
Share Paper
